Top

Published in:

01-01-2013 | Letter To the Editor

Predictive medicine and esophageal cancer response to preoperative chemotherapy

Author: Christof Hottenrott

Published in: Surgical Endoscopy | Issue 1/2013

Excerpt

Survival rates after esophageal cancer diagnosis still remain poor despite standardization of surgery and adjuvant treatment for resectable tumors. Currently, the US cancer statistics for patients with regional or stage II/III TNM stage cancer show high mortality rates. Many patients relapse and die after complete tumor resection (R0) and multimodal adjuvant treatment with chemotherapy or chemoradiotherapy, which is associated with toxic side effects. …

Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, Shannon WD, Payton JE, Kulkarni S, Westervelt P, Walter MJ, Graubert TA, Mardis ER, Wilson RK, DiPersio JF (2012) Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481(7382):506–510CrossRefPubMed

Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRef

Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586CrossRefPubMed

Roukos DH (2010) Next-generation sequencing and epigenome technologies: potential medical applications. Expert Rev Med Devices 7(6):723–726CrossRefPubMed

Misra S, Choi M, Livingstone AS, Franceschi D (2012) The role of endoscopic ultrasound in assessing tumor response and staging after neoadjuvant chemotherapy for esophageal cancer. Surg Endosc 26(2):518–522CrossRefPubMed

Welch CM, Elliott H, Danuser G, Hahn KM (2011) Imaging the coordination of multiple signalling activities in living cells. Nat Rev Mol Cell Biol 12(11):749–756CrossRefPubMed

Roukos DH (2011) Cancer genome explosion and systems biology: impact on surgical oncology? Ann Surg Oncol 18(1):12–15CrossRefPubMed

Roychowdhury S, Iyer MK, Robinson DR, Lonigro RJ, Wu YM, Cao X, Kalyana-Sundaram S, Sam L, Balbin OA, Quist MJ, Barrette T, Everett J, Siddiqui J, Kunju LP, Navone N, Araujo JC, Troncoso P, Logothetis CJ, Innis JW, Smith DC, Lao CD, Kim SY, Roberts JS, Gruber SB, Pienta KJ, Talpaz M, Chinnaiyan AM (2011) Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med 3(111):111ra121CrossRefPubMed

Ziogas D, Baltogiannis G, Fatouros M, Roukos DH (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247(4):714–715CrossRefPubMed

10.

Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7(10):719–726CrossRefPubMed

11.

Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068CrossRefPubMed

12.

Fatouros M, Roukos DH, Arampatzis I, Sotiriadis A, Paraskevaidis E, Kappas AM (2005) Factors increasing local recurrence in breastconserving surgery. Expert Rev Anticancer Ther 5(4):737–745CrossRefPubMed

13.

Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545CrossRefPubMed

14.

Roukos DH (2009) Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol 16(3):772–773CrossRefPubMed

15.

Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250CrossRefPubMed

16.

Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043CrossRefPubMed

17.

Roukos DH (2011) Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets. Expert Rev Med Devices 8(2):123–126CrossRefPubMed

18.

Roukos DH (2011) “Big” science: genome regulatory networks and novel molecular tools to improve health. Expert Rev Mol Diagn 11(2):123–126CrossRefPubMed

19.

Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555CrossRefPubMed

20.

Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350CrossRefPubMed

21.

Ziogas D, Roukos D (2008) Robotic surgery for rectal cancer: may it improve also survival? Surg Endosc 22(5):1405–1406CrossRefPubMed

22.

Roukos DH (2011) Translating epigenetics into an anticancer drug pipeline for solid tumors. Expert Rev Med Devices 8(4):409–413CrossRefPubMed

23.

Roukos DH (2010) Beyond HER2 and trastuzumab: heterogeneity, systems biology, and cancer origin research may guide the future for personalized treatment of very early but aggressive breast cancer. J Clin Oncol 28(17):e279–e280; author reply e282–e283CrossRefPubMed

24.

Roukos DH (2011) Chromatin: a key player in complex gene regulation and future cancer therapeutics. Epigenomics 3(4):395–399CrossRefPubMed

25.

Roukos DH (2012) Biotechnological, genomics and systems-synthetic biology revolution: redesigning genetic code for a pragmatic systems medicine. Expert Rev Med Devices 9(2):97–101CrossRefPubMed

26.

Roukos DH (2011) Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions. Pharmacogenomics 12(5):695–698CrossRefPubMed

27.

Roukos DH (2012) Spatiotemporal individual genome codelifestyle network: revolutionizing personal diagnostics. Expert Rev Mol Diagn 9(3):215–218CrossRef

28.

Roukos DH. (2012) Differential signalling transduction networks for clinical robustness. Expert Rev Proteomics 9(2):111–114CrossRefPubMed

29.

Roukos DH (2012) Longevity with systems medicine? Epigenome, genome and environment interactions network. Epigenomics 4(2):119–123CrossRefPubMed

Title: Predictive medicine and esophageal cancer response to preoperative chemotherapy
Author: Christof Hottenrott
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Surgical Endoscopy / Issue 1/2013
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI: https://doi.org/10.1007/s00464-012-2411-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Predictive medicine and esophageal cancer response to preoperative chemotherapy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Outcome of laparoscopic colectomy for cancer in elderly patients

Minilaparoscopy-assisted transrectal low anterior resection (LAR): a preliminary study

The learning curve for endoscopic submucosal dissection in an established experimental setting

Transanal rectosigmoid resection via natural orifice translumenal endoscopic surgery (NOTES) with total mesorectal excision in a large human cadaver series

Wait only to resuscitate: early surgery for acutely presenting paraesophageal hernias yields better outcomes

Progression from laparoscopic-assisted to totally laparoscopic distal gastrectomy: comparison of circular stapler (i-DST) and linear stapler (BBT) for intracorporeal anastomosis